Sep 30, 2026 09:09AM
Jan 7, 2026 04:05PM
Jan 7, 2025 08:00AM
Jun 6, 2024 05:48AM
Jun 5, 2024 11:04PM
Jun 4, 2024 05:14PM
Jun 4, 2024 05:06PM Annexon Announces Proposed Public Offering of Common Stock
Mar 1, 2024 04:15AM
Jan 8, 2024 05:28AM
Jan 7, 2024 08:00PM
Dec 27, 2023 06:30AM
Jan 9, 2023 04:57AM
Jan 8, 2023 09:00AM
Jan 8, 2023 09:00AM Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises
Jan 4, 2023 06:30AM
Jan 4, 2023 06:30AM
Jan 4, 2022 06:30AM
Jan 4, 2022 06:30AM
Aug 23, 2021 03:52PM
Jan 12, 2021 07:00AM
Jan 12, 2021 07:00AM Annexon Highlights Recent Achievements and Outlines Expected Key Milestones in 2021 for Its Broad Portfolio of Complement Therapeutics
Jan 5, 2021 07:00AM
Jan 5, 2021 07:00AM
Jul 28, 2020 04:05PM
Jul 28, 2020 04:05PM
Jul 24, 2020 01:24PM

301,139 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All